Progyny PGNY 深 滬
等待開盤 03-26 09:30:00 美东时间
17.75
-0.300
-1.66%
華盛通- 最 高18.355
- 今 開18.27
- 成交量 122.65万股
- 最 低 17.195
- 昨 收 18.05
- 總市值 14.54亿
- 52周最高 28.75
- 市盈率 靜 27.26
- 換手率 1.50%
- 52周最低 16.755
- 委 比 81.53%
- 總股本 8190.22万
- 歷史最高 68.32
- 量 比 0.73
- 振 幅 6.43%
- 歷史最低 13.29
- 每 手 1
- 風險率 2.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Barclays Maintains Overweight on Progyny, Lowers Price Target to $23
Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $29 to $23.
03-20 21:28
Small-cap high-quality stocks amid rising volatility
Small-cap stocks generally have a negative correlation with volatility, and as the VIX (VIX) has surged from a low of 13 late last year to above 25 this month amid the Iran conflict. Jill Carey Hall, ...
03-18 23:38
Progyny Announces Settlement Of Derivative Lawsuit Over Historical Non-Employee Director Compensation
On March 13, 2026, Progyny, Inc. (the "Company") issued a Notice of Pendency of Settlement of Derivative Action, which is attached hereto as Exhibit 99.1, in accordance with the terms of a settlement agreement the
03-14 04:21
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
Surgery Partners announced the appointment of Lloyd Dean as an independent director on its Board. Dean, a nationally recognized healthcare leader, previously served as CEO of CommonSpirit Health and Dignity Health, leading large-scale healthcare systems and advancing clinical quality. He has extensive experience in reducing health disparities and shaping public health policy. Dean expressed excitement about joining Surgery Partners during a perio...
03-12 22:12
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Canaccord Genuity Maintains Hold on Progyny, Lowers Price Target to $19
Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Hold and lowers the price target from $26 to $19.
03-12 01:38
Progyny (PGNY) Receives a Hold from Canaccord Genuity
Canaccord Genuity analyst Richard Close maintained a Hold rating on Progyny tod...
03-11 18:58
U.S. RESEARCH ROUNDUP- Howmet Aerospace, Nike, Oracle
U.S. RESEARCH ROUNDUP- Howmet Aerospace, Nike, Oracle March 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Howmet Aerospace, Nike and Oracle on Wednesday. HIGHLIGHTS * Howmet Aerospace HWM.N : RBC raises target price
03-11 15:10
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences
NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. announced that its leadership team members will participate in several investor conferences in March. Mark Livingston, CFO, will speak at Leerink Partners' Global Healthcare Conference on March 10. Pete Anevski, CEO, will discuss at Barclays' event on March 11 and also participate in a fireside chat at KeyBanc Capital Markets' forum on March 17. Melissa Cummings, COO, will join a panel on...
03-06 14:02
